Results from the follicular lymphoma (FL) outcomes in patients (pts) with relapsed/refractory (R/R) disease treated with systemic therapy in a real-world assessment (FLORA) study.

被引：0
|
作者：
Luminari, Stefano
Harnett, James
Thieblemont, Catherine
Prochazka, Katharina
Townsend, William
Radford, John
Serna, Angel
Jalbert, Jessica J.
Kamat, Siddhesh
Wang, Joy
Ambati, Srikanth R.
Mohamed, Hesham
Chaudhry, Aafia
Sanz, Hector
Hermans, Ruben
Maissenhaelter, Benedikt
Hampp, Christian
Bachy, Emmanuel
机构：
[1] Azienda Unita Sanit Locale RCCS Reggio Emilia, Hematol Unit, Reggio Emilia, Italy
[2] Regeneron Pharmaceut Inc, Tarrytown, NY USA
[3] Univ Paris Cite, Paris, France
[4] Hop St Louis, Assistance Publ Hop Paris, Hematooncol, Paris, France
[5] Med Univ Graz, Dept Clin Hematol, Univ Clin Internal Med, Graz, Austria
[6] Univ Coll London Hosp, Canc Res UK, London, England
[7] Univ Coll London Hosp, UCL Canc, London, England
[8] Univ Manchester, Manchester, England
[9] Manchester Acad Hlth Sci Ctr, Christie NHS Fdn Trust, Manchester, England
[10] Vall dHebron Hosp Univ, Dept Hematol, Barcelona, Spain
[11] IQVIA, Barcelona, Spain
[12] IQVIA, London, England
[13] IQVIA, Munich, Germany
[14] Hosp Civils Lyon, Dept Hematol, Lyon, France
[15] Univ Claude Bernard Lyon 1, Lyon, France
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2024年 / 42卷 / 16期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
7076
引用
收藏
页数：1
相关论文
共 50 条
  • [1] Trial in Progress: Follicular Lymphoma Outcomes in Relapsed/Refractory Patients Treated with Systemic Therapy in a Real-World Assessment (FLORA)
    Bachy, Emmanuel
    Damaj, Gandhi Laurent
    Ma, Qiufei
    Hampp, Christian
    Harnett, James
    Sobel, Rachel E.
    Jalbert, Jessica J.
    Quek, Ruben G. W.
    Wei, Wenhui
    Wu, Ning
    Mastey, Vera
    Wang, Joy
    Bajwa, Anit
    Maissenhaelter, Benedikt
    van Gils, Chantal
    Aggarwal, Shivani
    Chaudhry, Aafia
    Mohamed, Hesham
    Ambati, Srikanth R.
    Thieblemont, Catherine
    BLOOD, 2022, 140 : 5198 - 5200
  • [2] Real-world early outcomes of axicabtagene ciloleucel for relapsed or refractory (R/R) follicular lymphoma (FL).
    Jacobson, Caron Alyce
    Hemmer, Michael T.
    Hu, Zhen-Huan
    Frank, Matthew Joshua
    Popplewell, Leslie
    Ahmed, Nausheen
    Lin, Yi
    Best, Timothy
    Beygi, Sara
    Miao, Harry H.
    Fu, Christine
    Sun, Fang
    Xu, Hairong
    Pasquini, Marcelo C.
    JOURNAL OF CLINICAL ONCOLOGY, 2023, 41 (16)
  • [3] Outcomes in patients (pts) with relapsed/refractory (R/R) diffuse large B cell lymphoma (DLBCL) treated with systemic therapy from real world experience (ORCHID) study.
    Damaj, Gandhi Laurent
    Hampp, Christian
    Bachy, Emmanuel
    Prochazka, Katharina
    Jo, Jae-Cheol
    Kim, Tae Min
    Oberic, Lucie
    Townsend, William
    Jalbert, Jessica J.
    Ma, Qiufei
    Kamat, Siddhesh
    Wang, Joy
    Ambati, Srikanth R.
    Mohamed, Hesham
    Chaudhry, Aafia
    Thorley, Eileen
    Rippin, Gerd
    Harnett, James
    Thieblemont, Catherine
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (16)
  • [4] TRANSCEND FL: phase 2 study results of lisocabtagene maraleucel (liso-cel) in patients (pts) with relapsed/refractory (R/R) follicular lymphoma (FL)
    Borchmann, Peter
    Morschhauser, Franck
    Dahiya, Saurabh
    Palomba, M. Lia
    Garcia-Sancho, Alejandro Martin
    Reguera Ortega, Juan Luis
    Kuruvilla, John
    Jaeger, Ulrich
    Cartron, Guillaume
    Izutsu, Koji
    Dreyling, Martin
    Kahl, Brad
    Ghesquieres, Herve
    Ardeshna, Kirit
    Goto, Hideki
    Barbui, Anna Maria
    Abramson, Jeremy S.
    Fleury, Isabelle
    Mielke, Stephan
    Farazi, Thalia
    Fasan, Omotayo
    Lymp, James
    Vedal, Min
    Nishii, Rina
    Avilion, Ariel
    Papuga, Jessica
    Nastoupil, Loretta J.
    ONCOLOGY RESEARCH AND TREATMENT, 2024, 47 : 142 - 143
  • [5] Long-term follow-up of patients (pts) with relapsed or refractory (r/r) follicular lymphoma (FL) treated with copanlisib.
    Leppa, Sirpa
    Santoro, Armando
    Demeter, Judit
    Follows, George
    Lenz, Georg
    Kim, Won Seog
    Mollica, Luigina
    Nagler, Arnon
    Diong, Colin Phipps
    Provencio, Mariano
    Stevens, Don A.
    Trevarthen, David R.
    Wang, MingLu
    Wirtz, Oliver
    Miriyala, Ashok
    Vargas, Jose Garcia
    Childs, Barrett H.
    Zinzani, Pier Luigi
    Dreyling, Martin H.
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [6] Long-term Clinical Outcomes and Correlative Efficacy Analyses in Patients (Pts) With Relapsed/Refractory (r/r) Follicular Lymphoma (FL) Treated With Tisagenlecleucel in the ELARA Trial
    Dreyling, M.
    Dickinson, M.
    Martinez-Lopez, J.
    Kolstad, A.
    Butler, J.
    Ghosh, M.
    Popplewell, L.
    Chavez, J. C.
    Bachy, E.
    Kato, K.
    Harigae, H.
    Kersten, M. J.
    Andreadis, C.
    Riedell, P. A.
    Ho, P. J.
    Perez-Simon, J. A.
    Chen, A. I.
    Nastoupil, L. J.
    Tresckow, B. V.
    Ferreri, Maria A. J.
    Teshima, T.
    Patten, P. E.
    McGuirk, J. P.
    Petzer, A.
    Offner, F.
    Viardot, A.
    Zinzani, P. L.
    Malladi, R.
    Paule, I.
    Zia, A.
    Awasthi, R.
    Han, X.
    Germano, D.
    O'Donovan, D.
    Ramos, R.
    Masood, A.
    Thieblemont, C.
    Fowler, N.
    Schuster, S. J.
    ONCOLOGY RESEARCH AND TREATMENT, 2023, 46 : 306 - 308
  • [7] Long-Term Clinical Outcomes and Correlative Efficacy Analyses in Patients (Pts) with Relapsed/Refractory Follicular Lymphoma (r/r FL) Treated with Tisagenlecleucel in the Elara Trial
    Dreyling, Martin
    Dickinson, Michael
    Martinez Lopez, Joaquin
    Kolstad, Arne
    Butler, Jason P.
    Ghosh, Monalisa
    Popplewell, Leslie L.
    Chavez, Julio
    Bachy, Emmanuel
    Kato, Koji
    Harigae, Hideo
    Kersten, Marie Jose
    Andreadis, Charalambos
    Riedell, Peter A.
    Ho, Phoebe Joy
    Perez-Simon, Jose A.
    Chen, Andy
    Nastoupil, Loretta J.
    von Tresckow, Bastian
    Ferreri, Andres J. M.
    Teshima, Takanori
    Patten, Piers E. M.
    McGuirk, Joseph P.
    Petzer, Andreas
    Offner, Fritz
    Viardot, Andreas
    Zinzani, Pier Luigi
    Malladi, Ram
    Paule, Ines
    Zia, Aiesha
    Awasthi, Rakesh
    Han, Xia
    Germano, Davide
    O'Donovan, Darragh
    Ramos, Roberto
    Masood, Aisha
    Thieblemont, Catherine
    Fowler, Nathan H.
    Schuster, Stephen J.
    BLOOD, 2022, 140 : 1459 - 1463
  • [8] Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group
    A. Muntañola
    T. Baumann
    A. C. Caballero
    B. Sánchez-González
    S. Mercadal
    L. Escoda
    A. Soler
    L. Iserte
    M. Canet
    M. T. Villalobos
    L. Magnano
    M. Sorigué
    O. García
    A. Salar
    A. López-Guillermo
    J. M. Sancho
    Annals of Hematology, 2020, 99 : 1627 - 1634
  • [9] Results of R-ESHAP as salvage therapy in refractory/relapsed follicular lymphoma: a real-world experience on behalf of GELCAB group
    Muntanola, A.
    Baumann, T.
    Caballero, A. C.
    Sanchez-Gonzalez, B.
    Mercadal, S.
    Escoda, L.
    Soler, A.
    Iserte, L.
    Canet, M.
    Villalobos, M. T.
    Magnano, L.
    Sorigue, M.
    Garcia, O.
    Salar, A.
    Lopez-Guillermo, A.
    Sancho, J. M.
    ANNALS OF HEMATOLOGY, 2020, 99 (07) : 1627 - 1634
  • [10] Primary analysis of the Phase 2 ELM-2 study: Odronextamab in patients (pts) with relapsed/refractory follicular lymphoma (R/R FL)
    Chong, Geoffrey
    Taszner, Michal
    Novelli, Silvana
    Cho, Seok-Goo
    Villasboas, Jose C.
    Ubieto, Ana Jimenez
    Tessoulin, Benoit
    Poon, Michelle
    Tucker, David
    Walewski, Jan
    Song, Yuqin
    Bachy, Emmanuel
    Guidez, Stephanie
    Alonso, Aranzazu
    Jagadeesh, Deepa
    Luminari, Stefano
    Mayer, Laura Magnano
    Iskierka-Jazdzewska, Elzbieta
    Tani, Monica
    Cai, Jingxian
    Uppala, Amulya
    Shariff, Saleem
    Brouwer-Visser, Jurriaan
    Chaudhry, Aafia
    Mohamed, Hesham
    Ambati, Srikanth
    Kim, Tae Min
    CANCER RESEARCH, 2024, 84 (07)
12345